Morán, Javier <br/><br/>
Intranasal C3a treatment ameliorates cognitive impairment in a mouse model of neonatal hypoxic-ischemic brain injury.  [electronic resource] 

 -  Experimental neurology  04 2017 
 - 74-84 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1090-2430 
<br/><br/><label>Standard No.: </label>10.1016/j.expneurol.2017.01.001  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Animals, Newborn<br/>Brain--pathology<br/>Cell Death--drug effects<br/>Cognition Disorders--drug therapy<br/>Complement C3a--administration & dosage<br/>Disease Models, Animal<br/>Exploratory Behavior--drug effects<br/>GAP-43 Protein--biosynthesis<br/>Gliosis--prevention & control<br/>Hippocampus--pathology<br/>Hypoxia-Ischemia, Brain--drug therapy<br/>Injections, Intraventricular<br/>Male<br/>Mice<br/>Mice, Inbred C57BL<br/>Motor Activity--drug effects<br/>Neuroprotective Agents--administration & dosage<br/>Recognition, Psychology--drug effects<br/>Synapsins--biosynthesis